Close Menu

asset acquisition

Diagnovus has developed a suite of oncology and gastroenterology tests using PCR, next-generation sequencing, and gene expression analysis.

Roche Diagnostics announced today it has purchased a technology portfolio for microdissection of slide-mounted tissue sections from AvanSci Bio.

Laboratory Corporation of America has acquired forensics and DNA identification services firm Bode Technology Group.

Moody's assigned a provisional Baa2 rating to the proposed offering and affirmed BD's Prime-2 short-term rating.

NEW YORK (GenomeWeb) – Cepheid said after the close of the market on Wednesday that it has reached an agreement to acquire the customer relationships of its former distribution partner, the Laboratory Supply Company, for $21 million.

NEW YORK (GenomeWeb) – PDI said after the close of the market Wednesday that its Interpace Diagnostics subsidiary will enter the molecular diagnostics market through the acquisition of two microRNA-based from Asuragen.

NEW YORK (GenomeWeb) – Sequenom said after the close of the market Friday that it has sold its bioscience business, which includes its MassArray system, to Agena Bioscience for $31.8 million.

NEW YORK (GenomeWeb News) – Response Genetics today announced it has acquired the "key assets" of Pathwork Diagnostics, including its US Food and Drug Administration-cleared and Medicare-reimbursed test for diagnosing metastatic, poorly differentiated, and undifferentiated cancer.

NEW YORK (GenomeWeb News) – BioReference Laboratories said today that it will acquire certain assets of Edge Biosystems, a reagents and sequencing services company.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.